Federal grants to Ossium Health, Inc.
Ossium Health, Inc. in San Francisco, California received $4.0 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Allergy and Infectious Diseases Research, with $1.5 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$4.0 million
- Awards6
- Awarded in FY 2025$1.0 million
- Largest award$1.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 5 | $2.3 million |
| FY 2022 | 1 | $572,754 |
| FY 2023 | 0 | -$24,540 |
| FY 2024 | 1 | $123,392 |
| FY 2025 | 1 | $1.0 million |
Programs that fund Ossium Health, Inc.
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 2 | $1.5 million |
| Trans-NIH Research Support | 1 | $1.4 million |
| Cardiovascular Diseases Research | 2 | $935,754 |
| Biomedical Research and Research Training | 1 | $113,101 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 6 | $4.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Ossiostem-matched multipotent msc (M3): banked, low passage bone marrow msc for treatment of hematopoietic acute radiation syndrome. | Trans-NIH Research Support | December 29, 2020 | $1.4 million |
| Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury - abstract exposure to even moderate levels (<3 gy) of ionizing radiation can result in severe pancyotopenia, placing patients as wells as victims of accidental exp | Allergy and Infectious Diseases Research | August 14, 2024 | $1.4 million |
| Novel strategies for storage and recovery of cadaveric bone marrow stem cells | Cardiovascular Diseases Research | October 26, 2020 | $687,302 |
| A novel approach to mesenchymal stem cell transduction - project summary mesenchymal stem cells (MSC) are in clinical development for cardiovascular, neurologic, orthopedic, and other indications. Ossium is developing a novel source of msc from vertebral bodies (VBMSC). Genetic modification of vbmsc | Cardiovascular Diseases Research | September 20, 2021 | $248,452 |
| A novel and clinically feasible co-therapy of deceased donor bone marrow combined with donor-matched mesenchymal stem cells to establish immune tolerance | Allergy and Infectious Diseases Research | June 28, 2021 | $142,485 |
| Reducing a major cost burden of therapeutic cell manufacturing by selectivelyremoving toxic culture byproducts to allow recycling of media - abstract: the tremendous cost of cell-based therapies manufacturing is the significant threat to the success of cell/gene therapy treatments. The cell culture | Biomedical Research and Research Training | September 20, 2021 | $113,101 |
Questions people ask
How much federal grant money does Ossium Health, Inc. get?
$4.0 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Ossium Health, Inc. the most?
The Department of Health and Human Services, with $4.0 million in 6 awards.
What is Ossium Health, Inc.'s largest federal grant?
$1.4 million under Trans-NIH Research Support, with its first action in the period on December 29, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Ossium Health, Inc.?
Its largest are Allergy and Infectious Diseases Research, Trans-NIH Research Support and Cardiovascular Diseases Research.
Other grant recipients in San Francisco
- The Regents of the University of California, San Francisco
- California Public Utilities Commission
- City & County of San Francisco
- City & County of San Francisco
- Golden Gate Bridge, Highway & Transportation District
- City and County of San Francisco
- Wested
- San Francisco State University
Largest federal grant recipients in California · Federal grants in California